Reviewed

Antivirals for neurotropic viruses of pandemic potential

Waiver type - Procurement: Nonavailability

Agency: NATIONAL INSTITUTES OF HEALTH (7529) • Product Service Code (PSC) : 6505 | Last Modified: 08/07/2023

Procurement Summary

60 bottle BrainPhys Neuronal Medium 30 bottle N2 Supplement-B (100X), 5mL 20 bottle NeuroCult SM1 Neuronal Supplement 20 bottle N2 Supplement-A (100X), 5mL 15 bottle Hu Recom BDNF, ACF, 10 ug 15 bottle Hu Recom GDNF, ACF, 10ug 15 bottle Dibutyryl-cAMP, 500 mg

Waiver Rationale Summary

Market research and solicitation failed to identify any domestic end products that are equal to the antivirals for neurotropic viruses of pandemic potential that would fulfill the Government’s needs.

Did / Will the solicitation include one of the standard BAA provisions announcing the agency’s intention to provide a price preference for domestic end products and construction material?

Yes

Was a sources sought or Request for Information issued?

Yes

OMB Determination

Consistent with Policy

Product

DRUGS AND BIOLOGICALS

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Date Submitted

07/25/2023

Procurement Instrument Identifier (PIID)

Solicitation ID

75N95023Q00431

Procurement Stage

Post-solicitation

Expected Maximum Duration of the Proposed Waiver

0 - 6 months

Waiver Coverage

Individual Waiver

Funding Agency

NATIONAL INSTITUTES OF HEALTH